Maren Høland recently received the degree of Master of Science by the University of Oslo, Institute for Molecular Biosciences. In her masters project Maren investigated in situ expression of 11 different protein markers and their prognostic value in malignant peripheral nerve sheath tumors. The main findings were the identification of two different immunohistochemical protein expression profiles that could distinguish a high risk patient group from a low risk group, even among patients in complete remission.
The M.Sc. project was supervised by Dr. Matthias Kolberg and Prof Ragnhild A. Lothe (co-supervisor).
Maren has recently received a PhD grant from the Institute of Clinical Medicine, University of Oslo, and will work in the Lothe group at the Centre for Cancer Biomedicine.
Osterlund E, Hammarström K, Nunes L, Mathot L, Mezheyeuski A, Sjöblom T, Glimelius B(2025) Primary tumour location, molecular alterations, treatments, and outcome in a population-based metastatic colorectal cancer cohort BJC Rep, 3(1), 38 DOI 10.1038/s44276-025-00156-z, PubMed 40437037
Axcrona K, Axcrona U, Skotheim RI(2025) Re: Histopathologic Features and Transcriptomic Signatures Do Not Solve the Issue of Magnetic Resonance Imaging-invisible Prostate Cancers: A Matched-pair Analysis Eur Urol(in press) DOI 10.1016/j.eururo.2025.04.002, PubMed 40222874
Moosavi SH, Kryeziu K, Eilertsen IA, Nunes L, Hektoen M, Niederdorfer B, Reims HM, Syversveen T, Grut H, Dueland S, Line PD, Lothe RA, Sveen A(2025) Molecular prognostic factors for liver transplantation of unresectable metastatic colorectal cancer Br J Surg, 112(4) DOI 10.1093/bjs/znaf072, PubMed 40235343